Medicalgorithmics S.A.

Symbol: MDG.WA




Market price today

  • -518.8688

    P/E Ratio

  • 5.4927

    PEG Ratio

  • 251.81M

    MRK Cap

  • 0.00%

    DIV Yield

Medicalgorithmics S.A. (MDG-WA) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Medical - Devices
CEO:Mr. Maciej Gamrot
Full-time employees:120
Address:Central Tower

Medicalgorithmics S.A. provides cardiac diagnostic solutions in Poland, the United States, and internationally. The company offers PocketECG, a diagnostic solution for the diagnosis of arrhythmia that provides disclosure ECG signal, complete data, analysis, and comprehensive reporting; and PocketECG CRS for cardiac rehabilitation monitoring. It also provides ECG TechBot, a software using a set of algorithms for automatic analysis and interpretation of the ECG signal; PatchECG, a device enabling single-channel offline monitoring; and PocketECG IV that enables the PocketECG to be connected over the LTE band for continuous ECG signal transmission. In addition, the company offers information technology, biotechnology, ECG monitoring, and scientific research and development services; and manufactures and sells electro-medical equipment. Medicalgorithmics S.A. was founded in 2005 and is headquartered in Warsaw, Poland.

General Outlook

When we look at how much money they make before expenses, they keep 0.832% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.017%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.013%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.005% return, is a testament to Medicalgorithmics S.A.'s adeptness in optimizing resource deployment. Medicalgorithmics S.A.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.006%. Furthermore, the proficiency of Medicalgorithmics S.A. in capital utilization is underscored by a remarkable 0.007% return on capital employed.

Liquidity Ratios

Analyzing MDG.WA liquidity ratios reveals its financial health of the firm. The current ratio of 351.61% gauges short-term asset coverage for liabilities. The quick ratio (275.79%) assesses immediate liquidity, while the cash ratio (207.43%) indicates cash reserves.

Current Ratio351.61%
Quick Ratio275.79%
Cash Ratio207.43%

Profitability Ratios

MDG.WA profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -0.55% underscores its earnings before tax deductions. The effective tax rate stands at -143.46%, revealing its tax efficiency. The net income per EBT, 243.46%, and the EBT per EBIT, -32.96%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 1.67%, we grasp its operational profitability.

Pretax Profit Margin-0.55%
Effective Tax Rate-143.46%
Net Income per EBT243.46%
EBT per EBIT-32.96%
EBIT per Revenue1.67%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 3.52, it details the span from stock purchase to revenue. The 3 days it takes to settle debts showcases its creditor relations. Meanwhile, a 2 cash conversion cycle and 512.77% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

Days of Sales Outstanding276
Days of Inventory Outstanding470
Operating Cycle541.61
Days of Payables Outstanding159
Cash Conversion Cycle383
Receivables Turnover5.13
Payables Turnover2.30
Inventory Turnover0.78
Fixed Asset Turnover18.89
Asset Turnover0.35

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.02, and free cash flow per share, -0.94, depict cash generation on a per-share basis. The cash per share value, 2.15, showcases liquidity position.

Operating Cash Flow per Share0.02
Free Cash Flow per Share-0.94
Cash per Share2.15
Free Cash Flow to Operating Cash Flow Ratio-61.19
Cash Flow Coverage Ratio0.03
Short Term Coverage Ratio0.06
Capital Expenditure Coverage Ratio0.02
Dividend Paid and Capex Coverage Ratio0.02

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 4.68%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.06, we discern the balance between debt and equity financing. The long-term debt to capitalization, 2.60%, and total debt to capitalization, 5.79%, ratios shed light on its capital structure. An interest coverage of 6.72 indicates its ability to manage interest expenses.

Debt Ratio4.68%
Debt Equity Ratio0.06
Long Term Debt to Capitalization2.60%
Total Debt to Capitalization5.79%
Interest Coverage6.72
Cash Flow to Debt Ratio0.03
Company Equity Multiplier1.31

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 4.47, provides a glimpse into top-line earnings distributed across each share. Net income per share, -0.06, reflects the portion of profit attributed to each share. The book value per share, 9.61, represents the net asset value distributed per share, while the tangible book value per share, 2.06, excludes intangible assets.

Revenue Per Share4.47
Net Income Per Share-0.06
Book Value Per Share9.61
Tangible Book Value Per Share2.06
Shareholders Equity Per Share9.61
Interest Debt Per Share0.60
Capex Per Share-1.17

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -31.28%, indicates top-line expansion, while the gross profit growth, -28.79%, reveals profitability trends. EBIT growth, -97.48%, and operating income growth, -97.48%, offer insights into operational profitability progression. The net income growth, -103.20%, showcases bottom-line expansion, and the EPS growth, -101.89%, measures the growth in earnings per share.

Revenue Growth-31.28%
Gross Profit Growth-28.79%
EBIT Growth-97.48%
Operating Income Growth-97.48%
Net Income Growth-103.20%
EPS Growth-101.89%
EPS Diluted Growth-101.89%
Weighted Average Shares Growth68.98%
Weighted Average Shares Diluted Growth68.98%
Operating Cash Flow Growth-97.13%
Free Cash Flow Growth-84.30%
10-Year Revenue Growth per Share-2.47%
5-Year Revenue Growth per Share-91.91%
3-Year Revenue Growth per Share-83.43%
10-Year Operating CF Growth per Share-98.84%
5-Year Operating CF Growth per Share-99.85%
3-Year Operating CF Growth per Share101.98%
10-Year Net Income Growth per Share-101.89%
5-Year Net Income Growth per Share-101.50%
3-Year Net Income Growth per Share99.10%
10-Year Shareholders Equity Growth per Share-59.37%
5-Year Shareholders Equity Growth per Share-81.75%
3-Year Shareholders Equity Growth per Share-80.83%
10-Year Dividend per Share Growth per Share-100.00%
5-Year Dividend per Share Growth per Share-100.00%
Receivables Growth8.48%
Inventory Growth6.27%
Asset Growth11.86%
Book Value per Share Growth-31.59%
Debt Growth63100.00%
R&D Expense Growth-63.87%
SGA Expenses Growth-36.68%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 274,485,323.15, captures the company's total value, considering both debt and equity. Income quality, -0.31, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 59.77%, indicates the value of non-physical assets, and capex to operating cash flow, -6219.23%, measures reinvestment capability.

Enterprise Value274,485,323.15
Income Quality-0.31
Sales General and Administrative to Revenue0.07
Intangibles to Total Assets59.77%
Capex to Operating Cash Flow-6219.23%
Capex to Revenue-26.26%
Capex to Depreciation-478.40%
Graham Number3.60
Return on Tangible Assets-1.18%
Graham Net Net0.77
Working Capital30,933,000
Tangible Asset Value19,865,000
Net Current Asset Value14,162,000
Average Receivables8,076,500
Average Payables2,697,000
Average Inventory9,046,000
Days Sales Outstanding71
Days Payables Outstanding159
Days of Inventory On Hand470

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 3.23, and the price to book ratio, 3.23, reflect the market's valuation relative to the company's book value. The price to sales ratio, 5.84, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -22.61, and price to operating cash flows, 1644.99, gauge market valuation against cash flow metrics.

Price Book Value Ratio3.23
Price to Book Ratio3.23
Price to Sales Ratio5.84
Price Cash Flow Ratio1644.99
Price Earnings to Growth Ratio5.49
Enterprise Value Multiple112.94
Price Fair Value3.23
Price to Operating Cash Flow Ratio1644.99
Price to Free Cash Flows Ratio-22.61
Price to Tangible Book Ratio3.18
Enterprise Value to Sales6.37
Enterprise Value Over EBITDA116.70
EV to Operating Cash Flow1508.16
Earnings Yield-0.20%
Free Cash Flow Yield-3.78%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Medicalgorithmics S.A. (MDG.WA) on the WSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -518.869 in 2024.

What is the ticker symbol of Medicalgorithmics S.A. stock?

The ticker symbol of Medicalgorithmics S.A. stock is MDG.WA.

What is company IPO date?

IPO date of Medicalgorithmics S.A. is 2011-11-09.

What is company current share price?

Current share price is 25.300 PLN.

What is stock market cap today?

The market cap of stock today is 251805081.000.

What is PEG ratio in 2024?

The current 5.493 is 5.493 in 2024.

What is the number of employees in 2024?

In 2024 the company has 120.